Roivant Sciences Ltd (ROIV) saw downtrend of -2.29% in the recent trading with $14.08 being its most recent. The current price level -2.73% lower than the highest price of $14.48 marked by the stock while trading over the past 52-weeks, whereas it is 61.28% higher than the lowest price of $8.73 the company dropped to over past 52-weeks. The latest news story on ROIV appeared in (Barrons.com) under the title “Vivek Ramaswamy Sells $22.7 Million of Roivant Sciences Stock”.
Do analysts rate it as a buy, sell or hold?
Irrespective of recent performance, what’s important is what the future holds. In uncertain economic times, a clear picture is difficult to get. Analysts generally have a good understanding of the market works, which gives them a leg up in making predictions. Currently, the stock has been recommended as Strong Buy by 7 of the brokerage firms. Analyst ratings are often compiled into a single score from 1 to 5. The score of 1 signifies buy or strong buy, the score of 2 signifies outperform, the score of 3 means hold, and the score of 4 indicates underperform. The simple numeric range of brokerage firm referenced at the scale of 1 to 5 reads a current average recommendation of 1.17 for the stock.
Roivant Sciences Ltd Earnings – What Happened With ROIV
Coming around sales and income figures on ROIV Stock Income Statement, public trading companies under normal circumstances post earnings and revenues near to average estimates by the Wall Street analysts, but those could came either above or below estimates and known as surprise factor. Roivant Sciences Ltd (ROIV) last released financial results for the quarter that ended 9/30/2024, posting a surprise factor of -23.75% for net revenue.
ROIV – Roivant Sciences Ltd Stock Earnings Estimates
The perspective of Roivant Sciences Ltd (NASDAQ:ROIV)’s current quarter earnings identifies that analysts are in consensus over the estimate of -0.24 for stock’s EPS in the current quarter. Roivant Sciences Ltd (ROIV) last released financial results for the quarter that ended 9/30/2024, posting a surprise factor of -23.75% for net revenue. Company’s EPS for the last quarter was -0.3.
Roivant Sciences Ltd – Insider Activity and Holdings
Investors get the exact data about the key information of institutional ownership in a listed company through its 13F filings at the Stock Exchange Commission (SEC). The total number of common shares currently owned by the public is 682.23 million. ROIV does have institutional investors; and they hold 64.12% of the stock.
As on 2024-06-30, SB INVESTMENT ADVISERS (UK) LTD was the top most holder in Roivant Sciences Ltd (NASDAQ:ROIV) with an ownership of 71.36 million shares of the company or 9.6983 of the stake worth $754.29 million. The filing also reveals VIKING GLOBAL INVESTORS LP as the second largest holder in the company with a control over 9.3985 of the outstanding shares. Its stake is worth $730.98 million for having 69.16 million shares in hand.
QVT FINANCIAL LP also came holding a key position in the company during the recent quarter and it now holds 9.0674 of the outstanding shares. With this there are now 451.0 institutions which have possession in ROIV’s shares.
Key Metrics for ROIV
The liquidity is a key characteristic of any stock and is the main point of focus of both short-term as well as long term investors before start trading into a stock. In recently reported quarter, Roivant Sciences Ltd has a debt to equity ratio of 0.02.
